business-standard.com | March 3, 2023, 10:23 a.m.
Alembic Pharma slips 5%; board approves Rs 1,150 cr as impairment charges
| Alembic pharma
Read more
business-standard.com | March 1, 2023, 3:35 p.m.
Alembic Pharma gets USFDA approval to market generic cancer drug
| Alembic pharma
| Usfda
Read more
business-standard.com | Feb. 24, 2023, 7:15 a.m.
Trading strategies for Bata India and Alembic Pharma by Mehul Kothari
| Trading
| Bata india
| Alembic pharma
Read more
business-standard.com | Feb. 2, 2023, 8:39 p.m.
Alembic Pharma Q3 net dips 29% to Rs 122 cr, revenue rises to Rs 1,509 cr
| Alembic pharma q3
Read more
business-standard.com | Dec. 26, 2022, 5:30 p.m.
Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
| Alembic pharma
| Usfda
Read more
business-standard.com | Nov. 14, 2022, 2:38 p.m.
Alembic Pharma gets USFDA nod for generic cancer treatment medication
| Alembic pharma
| Usfda
Read more
economictimes.com | Nov. 11, 2022, 9:09 p.m.
Alembic Pharma Q2 Results: Firm posts Rs 133 crore-profit
| Alembic pharma q2 results
Read more
business-standard.com | Nov. 11, 2022, 6:56 p.m.
Alembic Pharma Q2 net profit dips 19% to Rs 133 crore on higher expenses
| Alembic pharma q2
Read more
business-standard.com | Oct. 18, 2022, 2:21 p.m.
USFDA issues four observations to Alembic Pharma's Panelav plant
| Usfda
| Alembic pharma
| Panelav
Read more
business-standard.com | July 29, 2022, 4:10 p.m.
Alembic Pharma receive USFDA approval to market drug for skin treatment
| Alembic
| Usfda
Read more
